Everything healthcare privacy officers, compliance leaders, and health system executives need to know about protecting patient data, detecting unauthorized access, and building a world-class privacy program.
Table of Contents
- What Is Patient Privacy Monitoring?
- Why It Matters: The Real Cost of Getting It Wrong
- The Types of Unauthorized Access You Need to Be Monitoring For
- Proactive vs. Reactive Monitoring: Where Most Programs Fall Short
- How to Build and Measure an Effective Patient Privacy Program
- How Technology and AI Are Changing Patient Privacy Monitoring
- What HIPAA Actually Requires – and Where the Rules Are Heading
- What to Look for in a Patient Privacy Monitoring Platform
Section 1: What Is Patient Privacy Monitoring?
Patient privacy monitoring is the systematic review and analysis of access to protected health information (PHI) within electronic health record (EHR) systems and other clinical applications – with the goal of detecting unauthorized, inappropriate, or suspicious access before it becomes a breach.
At its core, patient privacy monitoring answers a deceptively simple question: who is accessing patient records, and do they have a legitimate reason to do so?
Every interaction with a healthcare information system leaves a digital footprint. Every login, every record viewed, every lab result pulled, every chart printed. These events are captured in system audit logs. Patient privacy monitoring is the discipline of reviewing those logs systematically, at scale, to identify when access crosses the line from clinical necessity to unauthorized snooping, curiosity, or malice.
What Is Protected Health Information (PHI)?
Protected health information (PHI) is any individually identifiable health information that is created, received, maintained, or transmitted by a covered entity or business associate. PHI includes names, dates of birth, addresses, Social Security numbers, diagnoses, medications, treatment records, lab results, insurance information, and any other data that could be used to identify a patient.
Under HIPAA, covered entities – including hospitals, health systems, physician practices, health plans, and their business associates – are legally required to protect PHI from unauthorized use and disclosure.
What Is an EHR Audit Log?
An EHR audit log is an automatically generated record of every action taken within an electronic health record system. Audit logs capture who accessed a record, when the access occurred, what specific information was viewed or modified, and from what device or location. Under the HIPAA Security Rule (45 CFR §164.312(b)), covered entities are required to implement audit controls that record and examine activity in systems containing or using ePHI.
These logs are the raw material of patient privacy monitoring. Without a systematic process for reviewing them, they sit unused and violations go undetected.
What Is the Difference Between a Privacy Officer and a Security Officer in Healthcare?
Healthcare security officers focus on protecting systems, networks, and data from external threats: cyberattacks, ransomware, unauthorized network intrusion. Healthcare privacy officers, by contrast, focus on ensuring that the employees and authorized users who already have access to patient data are only using it for legitimate purposes.
In other words: security keeps bad actors out. Privacy ensures that the people already inside aren’t doing things they shouldn’t be.
In practice, these roles overlap significantly, and in smaller organizations they may be filled by the same person. But conceptually, patient privacy monitoring is primarily a privacy function – focused on insider access, behavioral patterns, and compliance with HIPAA’s minimum necessary standard.
Proactive vs. Reactive Patient Privacy Monitoring: A Definition
A reactive patient privacy monitoring program responds to breaches after they are reported: when a patient complains, a coworker tips off compliance, or an external audit surfaces a problem. Most programs start here. The challenge is that reactive monitoring catches violations late, after damage has already been done.
A proactive patient privacy monitoring program continuously analyzes EHR access data to detect anomalies and potential violations before they escalate. It uses technology – and increasingly, machine learning and artificial intelligence – to surface suspicious access patterns across all users, all records, all the time. Proactive monitoring is the standard that leading health systems are moving toward, and it is where HIPAA enforcement increasingly expects organizations to be.
Section 2: Why It Matters — The Real Cost of Getting It Wrong
Patient privacy breaches are not a hypothetical risk. They are a persistent, expensive, and increasingly scrutinized problem across the healthcare industry.
The Financial Cost of a Healthcare Data Breach
Healthcare has the highest average data breach cost of any industry, for the twelfth consecutive year. In 2025, the average cost of a healthcare data breach was $7.42 million per incident, down from a record $9.77 million in 2024 but still 67% above the global all-industry average of $4.44 million.
Those costs are not just fines. They include forensic investigations and crisis management ($1.47M on average), lost business and reputational damage ($1.38M), and post-breach response activities including legal fees and regulatory penalties ($1.20M). Beyond the numbers, breaches consume enormous staff time across security, legal, compliance, and IT teams – time that could be spent on patient care and operational priorities.
Healthcare data is uniquely attractive to attackers. Medical records command up to $500 each on the dark web, which is far more than credit card numbers or Social Security numbers, making healthcare organizations a persistent target for both external attackers and malicious insiders.
The Human Cost: Why Patients Care About Privacy
Privacy is not just a compliance issue. Research consistently shows that patients rank privacy as a top priority in their healthcare relationships – above concerns about cost in some studies. When patients don’t trust that their information will be protected, they withhold sensitive details from their providers, avoid seeking care they need, and lose confidence in the institutions they rely on.
A privacy breach is not just a legal event. It is a betrayal of the fundamental trust relationship between patient and provider.
Insider Threats: The Risk That Is Already Inside Your Walls
The most persistent and expensive source of healthcare privacy breaches is not the external hacker, it is the insider. Insider threats remain the second leading cause of healthcare data breaches, behind only hacking and IT incidents. But the financial and reputational impact of insider-related breaches is disproportionately high.
The annualized cost of managing insider security incidents averages $28.8 million per healthcare organization – a figure that encompasses not just fines, but the full operational cost of detecting, investigating, remediating, and preventing future incidents.
In 2025, 55% of surveyed healthcare organizations reported experiencing a patient data breach within the prior 12 months. When asked to identify the root cause of their most significant breach, 40% cited third-party vendor compromise and 25% cited insider threats, whether intentional or accidental.
What Happens When You Don’t Catch It
Organizations that fail to proactively monitor patient privacy access face a cascade of consequences:
- Regulatory penalties. OCR can levy civil monetary penalties ranging from hundreds of thousands to millions of dollars. Settlements for organizations that fail to prevent employee snooping include a $865,000 fine against UCLA Health, a $4.75 million settlement against Montefiore Medical Center, and a $240,000 settlement against Yakima Valley Memorial Hospital.
- Criminal charges. Employees who intentionally access patient records without authorization – particularly for personal gain – can face criminal prosecution. Dr. Huping Zhou became the first healthcare employee jailed for a HIPAA violation, sentenced to four months in federal prison for accessing 323 patient records after learning he would be dismissed.
- Civil litigation. While HIPAA does not create a private right of action, patients increasingly sue under state privacy laws, invasion of privacy claims, and class action theories. Mayo Clinic was named in a lawsuit after a physician accessed records without authorization – a single employee’s actions triggering potential class-wide exposure.
- Reputational damage. Health systems that experience widely publicized privacy breaches lose patient trust, face media scrutiny, and spend years rebuilding their compliance credibility.
- Operational disruption. A significant privacy investigation consumes enormous organizational resources – pulling privacy, legal, IT, and HR teams away from their core functions for weeks or months.
The case for investing in proactive patient privacy monitoring is not just ethical; it is financial as well.
Section 3: The Types of Unauthorized Access You Need to Be Monitoring For
Not all unauthorized access looks the same. Understanding the specific categories of privacy violations that occur in healthcare (and how to detect each one) is essential to building an effective monitoring program. These are the access categories that appear most frequently in patient privacy investigations.
1. Serial Snooping
Serial snooping refers to a pattern of unauthorized EHR access by an employee who repeatedly views patient records without a legitimate work-related reason. Unlike a one-time curiosity-driven access, serial snooping involves consistent, intentional behavior – often targeting specific patients (a neighbor, a celebrity, an ex-partner, a coworker) or broad categories of records (patients with specific diagnoses, patients involved in high-profile incidents).
Serial snooping is one of the most serious categories of patient privacy violation because the pattern indicates intent, not accident. It is also one of the hardest violations to detect without continuous, technology-assisted monitoring. Because no single access event is necessarily alarming, serial snooping can continue undetected for months or years under a purely reactive program – as a Harris Health case demonstrated, where one employee accessed 5,357 patient records over a ten-year span before being detected.
What monitoring should look for: Repeated access to the same patient records without clinical context, access patterns that do not align with the employee’s assigned patients or role, and access that occurs outside of normal work hours or from unusual locations.
2. Family Member Access
Family member access is one of the highest-volume categories in patient privacy monitoring, accounting for roughly 28% of all cases reviewed across healthcare organizations. It occurs when an employee accesses the medical records of a family member, spouse, partner, or household member – often believing the access is benign or even helpful.
The challenge with family member access is clinical context. The behavior often stems from genuine concern: an employee checking on a relative’s care, viewing their own family member’s test results out of worry. But even well-intentioned access is a policy violation when it bypasses the clinical disclosure workflows that exist to protect all patients equally.
What monitoring should look for: Employees accessing records of patients who share surnames, addresses, phone numbers, or emergency contacts with the employee. Modern platforms use relationship inference to flag potential family connections even without a direct name match.
3. Coworker Access
Coworker access occurs when one healthcare employee accesses the medical records of another employee without a care-related reason. This is one of the most common forms of EHR snooping – a nurse checking a colleague’s diagnosis, a front desk coordinator looking up a coworker’s upcoming appointment, or staff accessing records of a colleague involved in a workplace incident.
Coworker access is particularly sensitive because employees expect a degree of privacy at their workplace. When their personal health information is accessed by colleagues, the betrayal of trust can be significant, leading to HR conflicts, legal liability, and workforce morale issues – in addition to the HIPAA compliance implications.
What monitoring should look for: Employee-to-employee record access where no care relationship exists, particularly access clustered around HR events (leave of absence, injury reports, workers’ compensation claims) or workplace incidents.
4. Self-Access
Self-access violations occur when employees access their own medical records through their workforce credentials rather than through the patient portal or other authorized patient access channels. Many healthcare organizations explicitly prohibit this practice, and for good reason.
Employees often perceive accessing their own records as harmless. But self-access bypasses the clinical disclosure workflows designed to protect all patients, creates audit integrity issues, and can obscure more concerning behaviors (such as an employee modifying their own records).
What monitoring should look for: Access events where the accessing user’s employee ID matches the patient ID, or where name and demographic matches suggest the employee is viewing their own chart.
5. VIP Patient Access
VIP patient access refers to unauthorized viewing of records belonging to high-profile individuals: celebrities, politicians, executives, athletes, or other patients in the media spotlight. This category carries lower case volume but disproportionately high risk: a single unauthorized access to a VIP patient’s records can trigger massive reputational damage, regulatory scrutiny, and high-profile litigation.
UCLA Health was fined $865,000 after a physician accessed celebrity records without authorization. Health systems routinely receive media inquiries after high-profile patients are admitted. Without active VIP monitoring, these organizations are exposed every time a notable patient walks through their doors.
What monitoring should look for: Access to a curated list of designated VIP patients, unusual spikes in access to specific records, and access by employees with no care relationship to the patient.
6. Repeat Offenders
Repeat offenders are employees who have already been identified for one privacy violation and subsequently commit another. This category is lower in volume but high in organizational significance. A repeat offense indicates that the initial response (counseling, training, sanction) was insufficient to deter the behavior.
Repeat offender cases require escalated responses and are frequently indicators of deeper organizational issues: unclear policies, inadequate training, inconsistent enforcement, or management cultures that do not take privacy seriously.
What monitoring should look for: Cross-referencing new violation flags against historical case records to identify employees with prior violations. Technology platforms that maintain longitudinal employee access history make this significantly more efficient than manual methods.
7. Suspicious Activity
Suspicious activity is a catch-all category for access patterns that don’t fit neatly into other classifications but still warrant investigation. This includes unusual access volume (accessing hundreds of records in a short period), access at anomalous times (3am access from an IP not associated with a clinical facility), geographic anomalies (access from an unusual location), or patterns consistent with data exfiltration (systematic downloading or printing of records).
What monitoring should look for: Statistical outliers in access volume, timing, and geography. Machine learning platforms excel at this category because they can establish behavioral baselines for every user and flag deviations that human reviewers would miss.
8. Break the Glass Access
“Break the glass” (BTG) is an emergency access protocol that allows clinicians to temporarily override normal access restrictions to view records of patients they are not formally authorized to access – for example, in an emergency where a patient is unconscious and cannot provide consent.
Break the glass access is a legitimate and necessary function. But it is also susceptible to misuse. Employees may invoke BTG access to view records they are simply curious about, using the emergency exception as a cover. Without systematic post-event review, BTG access is essentially ungoverned.
What monitoring should look for: High volumes of unreviewed BTG access events, BTG access that doesn’t correlate with documented clinical activity, and BTG access patterns that cluster around specific employees or patient types. Note that BTG access can represent a significant proportion of total unreviewed alerts — in some health systems, this category accounts for more than 50% of all unreviewed alerts.
Section 4: Proactive vs. Reactive Monitoring – Where Most Programs Fall Short
Most patient privacy programs start the same way: reactively. A patient calls to report that a neighbor who works at the hospital looked at their records. A compliance officer receives a tip from an employee. An internal audit flags an anomaly. The privacy team investigates, resolves the case, documents the response, and moves on until the next complaint arrives.
This reactive model is not adequate for the privacy threat environment that healthcare organizations face today. Here is why.
The Problem with Reactive Programs
Reactive programs only catch what gets reported. Research consistently shows that the vast majority of privacy violations are never self-reported by the employees who commit them. Without continuous monitoring, the only violations that surface are the ones that come to light through patient complaints, colleague tips, or coincidental audits – a tiny fraction of the actual violation universe.
Reactive programs catch violations late. By the time a patient complaint triggers an investigation, the unauthorized access may have occurred weeks, months, or even years earlier. The Jackson Health employee who accessed 2,599 records did so over five years. The Harris Health employee who accessed 5,357 records did so over ten years. In both cases, the harm was done long before detection.
Reactive programs cannot demonstrate compliance. When OCR investigates a breach, one of the first questions they ask is what monitoring was in place. An organization that can only point to complaint-driven investigations has difficulty demonstrating that it took reasonable steps to protect PHI. An organization with continuous, documented monitoring is in a significantly better compliance position.
Reactive programs miss patterns. Serial snooping, by definition, involves repeated behavior that only becomes apparent when viewed across time. A single access event looks unremarkable. A pattern of 50 accesses to the same patient’s record over three months is unmistakable, but only if someone is looking at the full picture.
The Maturity Spectrum: Where Does Your Program Stand?
Patient privacy programs exist on a maturity spectrum, from minimal compliance efforts to sophisticated, AI-driven proactive monitoring. Understanding where your program sits — and where it needs to go — is the starting point for improvement.
Stage 1: Minimal/Reactive. No dedicated monitoring technology. Privacy violations are handled when reported. HIPAA training is conducted at onboarding, occasionally refreshed. Audit logs exist but are rarely reviewed. Most violations go undetected.
Stage 2: Manual Audit-Based. Privacy officers periodically review EHR audit logs, typically sampling specific patient populations (VIPs, employees) or responding to specific triggers. Case management is done in spreadsheets or basic tools. Coverage is limited by staff capacity.
Stage 3: Rule-Based Technology. The organization has implemented a privacy monitoring platform with rule-based alerting. Cases are generated automatically when access events match predefined criteria (e.g., employee accessing a patient with the same last name). False positive rates can be high, generating alert fatigue.
Stage 4: Analytics-Driven. The organization uses a platform with behavioral analytics and data-driven case prioritization. Cases are triaged by risk score. Privacy officers can focus their attention on high-probability violations rather than wading through noise. Benchmarking and trend reporting are available.
Stage 5: AI-Powered Proactive Monitoring. Machine learning continuously models normal access behavior for every user, detecting deviations that rules cannot anticipate. The platform surfaces genuine violations with high accuracy, minimizes false positives, and integrates with case management, breach notification, and compliance reporting workflows. This is the gold standard.
The Shift from Reactive to Proactive: What It Takes
Moving from a reactive to a proactive program requires investment in three areas: people, process, and technology.
People: Proactive monitoring requires dedicated staff capacity. Privacy investigators need time to review and resolve cases, not just respond to complaints. As case volume grows with improved detection, organizations need to plan for proportional staffing.
Process: Proactive programs need clear workflows for case triage, investigation, escalation, and documentation. The process needs to distinguish between proactive (platform-generated) and reactive (complaint-driven) cases and track them separately, so program metrics reflect true program performance rather than mixing apples and oranges.
Technology: Proactive monitoring at scale is not possible without purpose-built software. Manual audit log review cannot cover all users, all records, all the time. Technology is what makes comprehensive coverage achievable for a reasonably-sized privacy team.
Section 5: How to Build and Measure an Effective Patient Privacy Program
Building an effective patient privacy monitoring program is not a one-time project – it is an ongoing organizational capability. The following framework covers the essential components of a high-performing program, from foundation to optimization.
Step 1: Establish Clear Ownership and Cross-Functional Governance
Patient privacy touches every corner of a health system. An effective program requires clear ownership (the privacy officer) and active collaboration with compliance, IT/informatics, legal, HR, and clinical leadership.
Best-practice programs establish a privacy governance structure that defines: who owns privacy monitoring, who investigates cases, who makes disciplinary decisions, who handles breach notification, and how privacy metrics are reported to leadership and the board. Without this structure, cases fall through the cracks and accountability becomes diffuse.
Step 2: Document Your Policies and Procedures, and Enforce Them Consistently
HIPAA requires covered entities to maintain written privacy policies and to apply consistent sanctions for violations. This is not just regulatory box-checking. Policies and sanctions are the organizational backbone of a credible privacy program.
Effective privacy policies clearly define: what constitutes authorized access, the minimum necessary standard as applied to specific roles, prohibitions on accessing records of family members, coworkers, and oneself through workforce credentials, the escalation process for investigations, and the sanction framework for violations of varying severity.
Consistent enforcement matters as much as policy documentation. If similar violations result in different outcomes depending on the seniority or department of the employee involved, the program loses credibility and employees lose confidence that the organization takes privacy seriously.
Step 3: Implement Continuous Monitoring Technology
The single highest-leverage investment a privacy program can make is in a purpose-built patient privacy monitoring platform. Technology transforms monitoring from a sampling exercise to a comprehensive capability.
Modern patient privacy monitoring platforms connect to your EHR and other clinical systems, ingest audit log data continuously, apply machine learning and behavioral analytics to surface suspicious access, and generate prioritized case queues for privacy investigators. The best platforms achieve 95%+ accuracy in identifying genuine violations, dramatically reducing the false positive burden that makes manual review so inefficient.
81% of healthcare privacy and compliance leaders now use a dedicated monitoring tool. Organizations that have invested in machine learning-based platforms identify 69% more genuine violations than they were detecting just two years ago – not because more violations are occurring, but because they are now catching what they were previously missing.
Step 4: Separate and Track Proactive vs. Reactive Cases
One of the most important operational decisions a privacy program can make is to track proactive and reactive cases separately. Mixing them produces misleading metrics.
When a complaint-driven case is counted alongside a platform-detected case in the same violation rate calculation, the numbers become difficult to interpret and impossible to benchmark. Proactive and reactive cases have fundamentally different characteristics: proactive cases are generated systematically regardless of severity, while reactive cases are typically higher-severity violations that warranted a patient or employee complaint.
Tagging and reporting on cases by source allows privacy teams to accurately measure program performance, demonstrate the value of monitoring technology, and identify where their proactive program needs to be tuned.
Step 5: Prioritize Cases Using Risk Scoring and Data
Not all privacy cases warrant equal investigative attention. A privacy officer who treats a low-suspicion self-access event with the same urgency as a 500-record snooping pattern is not allocating their limited time effectively.
High-performing programs use risk scoring – typically a suspicion score generated by the monitoring platform – to prioritize investigations. Cases with high suspicion scores (indicating strong behavioral signals) get reviewed first. Cases with low scores may be triaged differently, reviewed in batches, or handled through automated workflows.
Data should also drive program-level decisions: which access categories are generating the most violations, which departments have the highest violation rates, whether violation rates are trending up or down over time, and how your program’s key metrics compare to peer benchmarks.
Step 6: Track the Right KPIs
A patient privacy program should be measured by a defined set of key performance indicators that reflect both program activity and program effectiveness.
Core metrics to track:
- Cases reviewed per month: reflects monitoring coverage and investigative capacity
- Violation rate: the percentage of reviewed cases that result in a confirmed violation; benchmarks vary by organization type and tier
- Accuracy rate: the percentage of cases that result in either a confirmed violation or a valid “good catch” (justified review); strong programs achieve 88%+
- False positive rate: the percentage of cases that result in no violation and no good catch; strong programs achieve under 5%
- Average resolution time: how quickly cases are investigated and closed; benchmark is approximately 21-24 days for many peer organizations
- Violations by category: which access types are driving the most violations in your organization
- Repeat offender rate: the percentage of violations committed by employees with prior violations on record
Step 7: Build a Culture of Privacy – Not Just a Compliance Program
Technology and policy are necessary but not sufficient. The organizations with the strongest patient privacy programs have built cultures where every employee understands that accessing a patient record without a legitimate need is a serious violation, not a technicality.
Culture-building requires ongoing education, not just annual HIPAA training. Leading programs invest in micro-learnings, scenario-based training, regular communications about privacy expectations, and visible leadership commitment to privacy as an organizational value. When employees know that access is monitored, that violations are detected, and that consequences are real and consistent, behavior changes.
Section 6: How Technology and AI Are Changing Patient Privacy Monitoring
The evolution of patient privacy monitoring technology over the past decade has been substantial. What began as manual audit log review has progressed through rules-based alerting to sophisticated machine learning platforms that continuously model user behavior across entire health systems. The next frontier is artificial intelligence – and it is already here.
From Rules to Machine Learning: Why It Matters
Early automated privacy monitoring tools relied on rule-based detection: flag any access where the employee’s last name matches the patient’s last name, flag any access outside of business hours, flag any employee who accessed more than X records in a day.
Rule-based systems have a fundamental problem: they generate enormous numbers of false positives. A large health system might have thousands of employees with common surnames. Access at 7am is not unusual for early shift clinicians. High-volume access is routine for care coordinators managing large caseloads.
Machine learning-based platforms take a different approach. Instead of applying rigid rules uniformly across all users, they build individual behavioral models for every user in the system – learning what normal looks like for a specific ICU nurse, a specific billing coordinator, a specific hospitalist. When a user’s access deviates meaningfully from their own baseline, the platform flags it not because it broke a rule, but because it is anomalous for that specific person in that specific context.
The result: dramatically lower false positive rates, dramatically higher accuracy, and dramatically better investigative efficiency. Privacy officers spend their time on cases that are genuinely likely to be violations, not sifting through thousands of alerts that turn out to be business as usual.
AI-Powered Features That Are Changing Privacy Programs
Behavioral anomaly detection. AI platforms continuously learn individual access patterns and surface deviations. A clinician who suddenly accesses three times their normal daily case volume, or who begins accessing records of patients in units they have never previously accessed, generates an alert even if no predefined rule has been broken.
Relationship inference. Advanced platforms can infer likely personal relationships between employees and patients — using demographic data, geographic proximity, and access pattern analysis — to flag potential family member or coworker access even without an obvious name match.
Suspicion scoring. AI platforms assign numerical suspicion scores to generated cases, allowing privacy teams to instantly see which cases are highest priority. This replaces the manual triage process and dramatically accelerates investigation timelines.
Natural language investigation assistance. The newest generation of AI-powered privacy platforms — including Prism Assistant for PrivacyPro — uses AI to assist privacy investigators directly, allowing them to ask questions of their own data, surface patterns, generate investigation summaries, and produce ready-to-present reports in a fraction of the time previously required.
Automated reporting. AI platforms generate compliance-ready reports, trend analyses, and benchmark comparisons automatically, replacing hours of manual data compilation with on-demand insights.
The Shadow AI Problem: A Growing Privacy Risk
While AI is improving privacy monitoring, it is simultaneously introducing a new category of patient privacy risk: shadow AI.
Shadow AI refers to staff use of third-party AI tools (consumer chatbots, AI writing assistants, clinical decision support tools) that have not been formally vetted or approved by the organization’s IT or compliance teams. When employees paste patient information into an unapproved AI tool to help draft a note, generate a summary, or answer a clinical question, they may be committing an impermissible PHI disclosure under HIPAA without knowing it.
The scale of this risk is significant. Only 35% of healthcare organizations have meaningful visibility into how their staff are using third-party AI tools. 75% of IT leaders believe their staff assumes that common AI tools like Microsoft Copilot are automatically HIPAA-compliant (a dangerous and incorrect assumption). Organizations with high levels of unmonitored AI adoption face an average of $670,000 in additional breach costs.
Addressing shadow AI requires a combination of policy (clear guidelines on approved AI tools), governance (an AI governance committee or equivalent), training (employee education on when AI use constitutes a PHI risk), and technology (monitoring solutions that can detect unusual data patterns consistent with AI-assisted workflows).
What an AI Governance Committee Looks Like and Why Privacy Needs to Be at the Table
As healthcare organizations increasingly adopt AI tools across clinical and administrative functions, AI governance has become a critical compliance function. An AI governance committee is an interdisciplinary group, typically including representation from IT, legal, compliance, privacy, clinical operations, and executive leadership, responsible for evaluating, approving, and monitoring AI tools deployed within the organization.
For privacy officers, the key question is: how do you ensure that patient privacy is a core consideration in the AI evaluation process, not an afterthought?
The most effective approach is to establish a formal privacy review as a required component of the AI approval workflow. Before any AI tool that touches PHI is approved, the privacy office should evaluate: what data the tool ingests and how it is used, whether the vendor has executed a Business Associate Agreement (BAA), what encryption and access controls are in place, whether the tool produces outputs that could constitute PHI disclosure, and what ongoing monitoring is required post-deployment.
How long does it take to vet an AI tool at a large health system? The honest answer varies significantly. Organizations with mature AI governance structures may complete a review in 4-8 weeks for lower-risk tools. For tools that touch clinical data at scale, the process can extend to 6 months or longer, incorporating security reviews, privacy impact assessments, legal review, clinical validation, and executive approval. Organizations just standing up governance functions often take longer at first, but build speed as the process matures.
AI-Specific Privacy Risks Worth Understanding
Training data risk. Some AI tools improve their models by training on user inputs. If an employee enters patient information into one of these tools, that PHI may be incorporated into the model’s training data, potentially exposing it to other users of the platform.
Output risk. AI tools can generate outputs that contain or reveal PHI – for example, a summary that reproduces identifiable patient details. Without clear policies on how AI outputs are handled, these outputs may be stored, shared, or disclosed inappropriately.
Vendor risk. Business associate liability extends to AI vendors who process PHI on behalf of covered entities. Organizations must evaluate AI vendors with the same rigor applied to any other business associate – including signing a BAA, assessing their security posture, and understanding their data retention and use policies.
Section 7: What HIPAA Actually Requires and Where the Rules Are Heading
HIPAA’s patient privacy requirements are not new, but they are more actively enforced than ever. And, a significant regulatory update is currently working its way through the system. Here is what healthcare organizations need to know.
What HIPAA Requires for Patient Privacy Monitoring
The HIPAA Security Rule, codified at 45 CFR §164.312(b), requires covered entities to “implement hardware, software, and/or procedural mechanisms that record and examine activity in information systems that contain or use electronic protected health information.”
This language is intentionally broad. HIPAA does not prescribe a specific monitoring approach or technology. But OCR’s enforcement history makes clear what “examine activity” means in practice: organizations are expected to actually review audit logs, not merely collect them. An organization that generates audit logs but never looks at them is not in compliance with the spirit – or, in OCR’s view, the letter – of the Security Rule.
The HIPAA Privacy Rule (45 CFR §164.530) further requires administrative safeguards including procedures to detect privacy violations and a sanction policy for workforce members who violate privacy policies. Both rules work in tandem to require organizations to actively monitor access and respond to violations when detected.
The Minimum Necessary Standard
The minimum necessary standard is one of the most important – and most commonly misunderstood – requirements in HIPAA. It requires that covered entities make reasonable efforts to limit access to and use of PHI to the minimum necessary to accomplish the intended purpose.
In practical terms, the minimum necessary standard means that employees should only access the records they need for their specific job function. A billing specialist should not access clinical notes beyond what is needed for billing. A unit nurse should not access records of patients outside their assigned unit. A security guard should not access patient medical records at all.
Implementing the minimum necessary standard requires both technical controls (role-based access restrictions) and monitoring (to detect when employees access records beyond their role’s scope). Technology alone cannot enforce minimum necessary – monitoring is what catches the gap between what the system permits and what the policy allows.
HIPAA Breach Notification Rule: What Triggers It
Under the HIPAA Breach Notification Rule, covered entities must notify affected patients, HHS, and in some cases prominent media outlets when a breach of unsecured PHI occurs. The notification must be made “without unreasonable delay and in no more than 60 calendar days from the discovery of a breach.”
For internal breaches, the critical question is whether unauthorized access constitutes a “breach” requiring notification. The answer: in most cases, yes. Organizations are required to conduct a four-factor breach risk assessment to determine notification obligations, and confirmed unauthorized access to PHI typically triggers them.
Organizations with proactive monitoring catch violations earlier, enabling faster breach risk assessments, more timely notifications, and better documentation of their compliance response – all of which matter significantly if OCR investigates.
The HIPAA Security Rule Update: What Is Proposed and What Is Coming
In January 2025, HHS published a Notice of Proposed Rulemaking (NPRM) proposing the most significant updates to the HIPAA Security Rule since 2013. The proposed changes represent a substantial modernization of the rule for the AI and cloud era.
Key proposed changes include:
- Elimination of the “addressable” vs. “required” distinction for many technical safeguards, converting previously flexible requirements into mandatory ones
- Technology asset inventory requirements: organizations would be required to maintain a current, accurate inventory of all technology assets that touch ePHI, including AI tools
- Enhanced incident response requirements: more detailed and prescriptive requirements for breach response plans and testing
- Stricter encryption standards: ePHI at rest and in transit would need to meet updated encryption requirements
- Network segmentation: requirements to isolate systems containing ePHI from other systems
- Multi-factor authentication: would become required rather than addressable for systems accessing ePHI
The rule generated significant industry pushback during the comment period, primarily focused on implementation cost and timeline. As of this writing, the rule has not been finalized, and legal challenges have complicated its trajectory. However, the direction is clear: the HIPAA Security Rule is moving toward more prescriptive, modern requirements that reflect today’s threat environment.
What privacy and compliance teams should do now: Regardless of when the final rule takes effect, the proposed requirements represent current best practices. Organizations that begin closing gaps now, particularly around technology asset inventories, AI governance, and incident response planning, will be better positioned for compliance, better protected against breaches, and better prepared for OCR scrutiny.
State-Level Patient Privacy Laws: The Emerging Patchwork
Beyond HIPAA, a growing number of states have enacted or proposed healthcare data privacy laws that impose additional obligations on covered entities. As of 2025, more than 215 health data and AI-related bills had been introduced across 44 states, with 21 enacted in 2025 alone.
Texas’s Responsible AI Governance Act (effective January 1, 2026) requires patients to be informed when AI supports their care. Colorado has enacted comprehensive AI governance requirements. Multiple states have introduced laws expanding patient privacy rights beyond HIPAA’s minimum floor.
Multi-state health systems need to treat this patchwork as a compliance reality, not a future concern. The practical approach: identify the strictest requirements across your operating states and implement them systemwide, rather than trying to maintain state-by-state variation.
Section 8: What to Look for in a Patient Privacy Monitoring Platform
The patient privacy monitoring software market has matured significantly. There are meaningful differences between platforms, and choosing the right one has substantial implications for your program’s effectiveness, your team’s efficiency, and your organization’s compliance posture. Here is what to evaluate.
1. Machine Learning vs. Rule-Based Detection
The most important distinction in the market is between platforms that use genuine machine learning to model individual user behavior, and those that rely primarily on rules. As discussed in Section 6, rule-based systems generate high false positive rates that burden privacy teams and lead to alert fatigue.
Ask vendors directly: how does your platform determine which access events to flag? Can it learn the normal access behavior of individual users? Does it adapt over time as users’ roles and workflows change? What is your customers’ average false positive rate?
The best platforms achieve false positive rates under 5% – meaning more than 95% of the cases your team reviews will turn out to be genuine violations or legitimate good catches worth investigating.
2. Accuracy and Case Quality
Related to false positives, but worth evaluating separately: how accurate is the platform at surfacing cases that are worth investigating? Accuracy is typically measured as the percentage of reviewed cases that result in either a confirmed violation or a documented good catch.
High-performing platforms help organizations achieve accuracy rates of 95% or higher. This means privacy investigators spend their time on cases that genuinely warrant their attention, not chasing dead ends.
3. Coverage: Which Systems Can It Monitor?
EHR systems (Epic, Oracle Health’s Cerner, MEDITECH) are the primary source of PHI access events, but they are not the only ones. Clinical applications, imaging systems, laboratory systems, and pharmacy platforms also contain PHI and generate audit data.
Evaluate each platform’s connectivity: which EHR systems does it integrate with natively? Can it ingest data from ancillary clinical systems? How does it handle organizations with multiple EHR instances or systems from different vendors?
4. Case Management and Investigation Workflow
A privacy monitoring platform is not just a detection tool – it is a case management system. How the platform handles case workflow from alert generation through investigation, documentation, resolution, and reporting has a major impact on investigator efficiency.
Look for: intuitive case queues with clear prioritization, access to relevant context within each case (the employee’s access history, the patient’s access log, the specific records accessed), easy documentation tools, configurable workflows, and integration with your organization’s existing HR and legal processes.
5. Reporting and Benchmarking
Privacy programs need to report upward to privacy leadership, compliance committees, legal, and the board. The platform should make reporting easy: on-demand metrics, trend analyses, violation rates by category and department, and year-over-year comparisons.
Benchmarking is particularly valuable: can the platform show you how your program’s key metrics compare to peer organizations of similar size and type? Benchmark data helps privacy officers make the case for program investment and identify areas for improvement.
6. AI and Automation Capabilities
The best platforms are beginning to incorporate AI-assisted investigation features that go beyond detection, helping privacy investigators understand cases faster, surface patterns across cases, and generate investigation documentation automatically.
Evaluate whether the platform offers: AI-assisted case summarization, natural language querying of your own access data, automated report generation, and intelligent triage recommendations. These features are not universally available today, but they represent where the market is headed and where leading organizations are gaining meaningful efficiency advantages.
7. Implementation, Training, and Customer Success
A privacy monitoring platform is only as good as your team’s ability to use it effectively. Evaluate the vendor’s implementation process, training resources, and ongoing customer success support.
Ask: how long does implementation typically take? What training is provided for privacy investigators? Is there a dedicated customer success manager? How does the vendor handle configuration updates as your program evolves? Are there user communities or peer networks where you can learn from other health system customers?
8. Security, Compliance, and Privacy of the Platform Itself
Your privacy monitoring platform will have access to sensitive PHI access data, so it must be treated with the same security rigor as any other system that touches patient information. Evaluate: does the vendor sign a Business Associate Agreement? What data retention and deletion policies apply? Where is data processed and stored? What security certifications does the vendor hold? What is their breach notification process?
The Bottom Line: Patient Privacy Monitoring Is Not Optional
The healthcare organizations that take patient privacy seriously – that invest in the people, processes, and technology to monitor access proactively, detect violations early, and build cultures of accountability – consistently outperform those that treat privacy as a compliance checkbox.
They catch violations before they become breaches. They resolve cases faster. They report stronger KPIs to leadership. They face lower regulatory risk. And they maintain the patient trust that is foundational to the healthcare relationship.
Whether your organization is just beginning its privacy monitoring journey or looking to advance from a rules-based system to AI-powered proactive monitoring, the path forward is the same: understand where you stand, identify where the gaps are, and invest in closing them – before the next breach happens on your watch.
About Bluesight’s PrivacyPro: PrivacyPro is the industry’s leading patient privacy monitoring platform, used by health systems across the country to detect unauthorized EHR access, investigate violations, and build stronger compliance programs. Powered by machine learning, PrivacyPro helps privacy teams monitor every access, prioritize high-risk cases, and demonstrate compliance with confidence.
To learn more or request a demo, visit bluesight.com/privacypro.